PUMA BIOTECHNOLOGY, INC. Fair Value Adjustment of Warrants
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Fair Value Adjustment of Warrants of $18.20 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2015-03-02
- PUMA BIOTECHNOLOGY, INC. fair value adjustment of warrants for the quarter ending 2012-12-31 was $12.00M.
- PUMA BIOTECHNOLOGY, INC. fair value adjustment of warrants for the quarter ending 2012-09-30 was $6.50M.
- PUMA BIOTECHNOLOGY, INC. fair value adjustment of warrants for the quarter ending 2012-06-30 was $65.30K.
- PUMA BIOTECHNOLOGY, INC. fair value adjustment of warrants for fiscal 2012 was $18.20M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2012-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $18.50M derived: sum of 2 quarters · filed 2015-03-02 | $18.57M derived: sum of 3 quarters · filed 2015-03-02 | $18.20M 10-K · filed 2015-03-02 |
| 2012-09-30 | $6.50M 10-Q · filed 2013-11-12 | $6.57M derived: sum of 2 quarters · filed 2013-11-12 | $6.20M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $65.30K 10-Q · filed 2013-08-06 | $214.60K 10-Q · filed 2013-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |